AB SCIENCE Investor Relations Material
Latest events
Status Update
AB SCIENCE
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from AB SCIENCE
Access all reports
AB Science is a biotechnology company specializing in the research, development, and commercialization of targeted therapies for serious diseases. The company focuses on small molecule drugs designed to address conditions in oncology, neurodegenerative disorders, and inflammatory diseases. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Key slides for AB SCIENCE
Status Update
AB SCIENCE
Status Update
AB SCIENCE
Latest articles
)
Adobe: Equipping the Architects of Digital Expression
The story of how Adobe grew from a small garage upstart to one of the largest and most dominant software companies in the world.
21 Mar 2025
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
Ticker symbol
AB
Country
🇫🇷 France